After watching the Baker interview over a few times, my biggest take away is around the FDA/TGA approval for platform designation. I agree that the market has missed this, or its misunderstood. Once this approval is granted, it really will be a game changer!
To have the ability to be able to pivot into different cancer treatments by creating a new lentivirus, whilst the rest of the manufacturing process remains the same, is massive.
Future looking very exciting for us
After watching the Baker interview over a few times, my biggest...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
16.0¢ |
Change
0.005(3.23%) |
Mkt cap ! $168.2M | |||
| Open | High | Low | Value | Volume |
| 15.5¢ | 16.5¢ | 15.5¢ | $495.0K | 3.108M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 59544 | 16.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.5¢ | 114617 | 6 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |